LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Palbociclib | 0.31623 | 7.66 | 770.25 | 1006 | 1090 | 0.9229 | 0.7041 | MN20160304_L02 | I07 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.31623 | 10.06 | 770.25 | 1022 | 1218 | 0.8387 | 0.5332 | MN20160304_L02 | C05 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.31623 | 10.06 | 770.25 | 1104 | 1218 | 0.9060 | 0.7229 | MN20160304_L02 | I07 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.31623 | 12.28 | 770.25 | 1101 | 1358 | 0.8107 | 0.5475 | MN20160304_L02 | C05 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.31623 | 12.28 | 770.25 | 1167 | 1358 | 0.8593 | 0.6616 | MN20160304_L02 | I07 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.31623 | 14.50 | 770.25 | 1130 | 1497 | 0.7547 | 0.4914 | MN20160304_L02 | C05 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.31623 | 14.50 | 770.25 | 1184 | 1497 | 0.7908 | 0.5657 | MN20160304_L02 | I07 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.31623 | 16.73 | 770.25 | 1157 | 1664 | 0.6951 | 0.4420 | MN20160304_L02 | C05 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.31623 | 16.73 | 770.25 | 1180 | 1664 | 0.7089 | 0.4677 | MN20160304_L02 | I07 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.31623 | 18.95 | 770.25 | 1159 | 1832 | 0.6325 | 0.3865 | MN20160304_L02 | C05 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.31623 | 18.95 | 770.25 | 1186 | 1832 | 0.6472 | 0.4123 | MN20160304_L02 | I07 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.31623 | 21.17 | 770.25 | 1126 | 2008 | 0.5607 | 0.3160 | MN20160304_L02 | C05 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.31623 | 21.17 | 770.25 | 1227 | 2008 | 0.6109 | 0.4004 | MN20160304_L02 | I07 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.31623 | 23.39 | 770.25 | 1142 | 2244 | 0.5088 | 0.2908 | MN20160304_L02 | C05 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.31623 | 23.39 | 770.25 | 1240 | 2244 | 0.5525 | 0.3615 | MN20160304_L02 | I07 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.31623 | 25.62 | 770.25 | 1142 | 2514 | 0.4541 | 0.2595 | MN20160304_L02 | C05 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.31623 | 25.62 | 770.25 | 1306 | 2514 | 0.5193 | 0.3625 | MN20160304_L02 | I07 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.31623 | 27.84 | 770.25 | 1187 | 2833 | 0.4189 | 0.2587 | MN20160304_L02 | C05 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.31623 | 27.84 | 770.25 | 1397 | 2833 | 0.4930 | 0.3727 | MN20160304_L02 | I07 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.31623 | 30.06 | 770.25 | 1245 | 3106 | 0.4008 | 0.2696 | MN20160304_L02 | C05 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.31623 | 30.06 | 770.25 | 1502 | 3106 | 0.4836 | 0.3937 | MN20160304_L02 | I07 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.31623 | 32.28 | 770.25 | 1299 | 3392 | 0.3829 | 0.2768 | MN20160304_L02 | C05 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.31623 | 32.28 | 770.25 | 1576 | 3392 | 0.4645 | 0.3975 | MN20160304_L02 | I07 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.31623 | 34.50 | 770.25 | 1365 | 3712 | 0.3677 | 0.2869 | MN20160304_L02 | C05 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.31623 | 34.50 | 770.25 | 1729 | 3712 | 0.4658 | 0.4282 | MN20160304_L02 | I07 |